Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Travere Therapeutics Inc TVTX

Healthcare Biotechnology
Travere Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. Sparsentan is also in late-stage development for... see more

Recent & Breaking News (NDAQ:TVTX)

Stull, Stull & Brody Announces the Investigation of Possible Breaches of Fiduciary Duties of Officers and Directors of Retrophin, Inc. (NASDAQ: RTRX)

GlobeNewswire November 4, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Retrophin, Inc. of Class Action Lawsuit and Upcoming Deadline -- RTRX

GlobeNewswire November 4, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Retrophin, Inc. To Contact Brower Piven Before The December 19, 2014 Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire October 31, 2014

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Retrophin, Inc. (RTRX) to Contact the Firm

Marketwired October 31, 2014

Retrophin to Report Third Quarter 2014 Financial Results

Business Wire October 30, 2014

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX

Marketwired October 27, 2014

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Retrophin, Inc.

Marketwired October 24, 2014

Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Retrophin, Inc. - RTRX

GlobeNewswire October 24, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Retrophin, Inc. to Contact Brower Piven Before the December 19, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- RTRX

GlobeNewswire October 23, 2014

Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Has Been Filed in the Southern District of New York Against Retrophin, Inc. -- RTRX

GlobeNewswire October 22, 2014

Harwood Feffer LLP Announces Investigation of Retrophin, Inc.

PR Newswire October 22, 2014

Robbins Arroyo LLP: Retrophin, Inc. (RTRX) Misled Shareholders According to a Recently Filed Class Action

GlobeNewswire October 22, 2014

INVESTOR ALERT: Class Action Lawsuit Against Retrophin, Inc. Announced by Glancy Binkow & Goldberg LLP

Business Wire October 22, 2014

Hagens Berman Announces the Filing of a Class Action Against Retrophin, Inc. (RTRX)

GlobeNewswire October 22, 2014

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Retrophin, Inc. (RTRX) To Contact The Firm

PR Newswire October 21, 2014

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Against Retrophin, Inc. and Certain of Its Officers - RTRX

GlobeNewswire October 21, 2014

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX

GlobeNewswire October 21, 2014

Pomerantz Law Firm Announces the Filing of a Class Action Against Retrophin, Inc. and Certain Officers -- RTRX

GlobeNewswire October 20, 2014

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Retrophin, Inc.

PR Newswire October 14, 2014

Retrophin Announces Divestment of Non-Core Assets to Turing Pharmaceuticals

Business Wire October 14, 2014